Concepedia

Ralf Grunewald

RG

8

Publications

2.4K

Citations

8

H-Index

1985

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Humboldt-Universität zu Berlin

Cal Poly Humboldt

Ralf Grunewald is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

1985–2000

8

Publications

8

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

James L. Abbruzzese, Ralf Grunewald, Elizabeth A. Weeks et al. · Journal of Clinical Oncology · 1991 · 757 citations

, , +12

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

William Plunkett, Peng Huang, Yi-Zheng Xu et al. · PubMed · 1995 · 756 citations

Saturation of 2?, 2?-difluorodeoxycytidine 5?-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

Ralf Grunewald, James L. Abbruzzese, Peter G. Tarassoff et al. · Cancer Chemotherapy and Pharmacology · 1991 · 249 citations

, , +6

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study.

Ralf Grunewald, Hagop M. Kantarjian, Meiqing Du et al. · Journal of Clinical Oncology · 1992 · 217 citations

Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.

Ralf Grunewald, Hagop M. Kantarjian, M Keating et al. · PubMed · 1990 · 210 citations

, , +15

Rows per page

1–5 of 8